跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 107 条关于
“Pablo Legorreta”
全部
107
临床试验
28
药物
7
机构
18
资讯
54
去年
Royalty Pharma Secures 99.9% Shareholder Approval for $1.1 Billion External Manager Acquisition
去年
Biogen Secures $250M from Royalty Pharma to Advance Lupus Antibody into Phase III Trials
9个月前
Denali Therapeutics Secures $275 Million Royalty Deal with Royalty Pharma for Hunter Syndrome Therapy
10个月前
Royalty Pharma Acquires $310 Million AMVUTTRA Royalty Interest from Blackstone Life Sciences
去年
Royalty Pharma Acquires $950 Million IMDELLTRA Royalty Rights from BeOne Medicines
去年
Zenas BioPharma Secures $300 Million Royalty Deal with Royalty Pharma for Obexelimab Development
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
8个月前
Teva and Royalty Pharma Announce $500 Million Funding Agreement for Vitiligo Treatment TEV-'408
去年
Revolution Medicines Secures $2 Billion Funding Deal with Royalty Pharma for RAS Cancer Drug Development
3天前
Royalty Pharma Gives $7.5M to Blood Cancer United's Therapy Acceleration Program, Marking New Venture Philanthropy Phase
第 1 页,共 6 页
上一页
下一页